Brainscape's Knowledge GenomeTM


Top Flashcards (Certified)
All Flashcards

Clinical Nutrition 1 > NAFLD and NASH Part II > Flashcards

NAFLD and NASH Part II Flashcards

(79 cards)

Start Studying
1
Q

Wha may excess fat and fructose within the diet lead to?

A

Intestinal dysbiosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe intestinal dysbiosis and how it relates to NAFLD

A

Microbes slip through the intestinal epithelium, as there is increased intestinal permeability, and will contribute to fatty and apoptotic hepatocytes and fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The severity of nonalcoholic fatty-liver disease is associated with what? (2)

A
  • Gut dysbiosis

- Shift in the metabolic function of the gut microbiota

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is diagnostic of NASH?

A

Inflammation and steatosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What indicates that NASH has progressed?

A

Liver fibrosis, staging, cirrhosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

NAFLD can sometimes be ____

A

a slient disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How is NAFLD usually discovered?

A

Incidental LFT, bright liver on imaging or hepatomegaly during routine check ups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

NAFLD is _____ and frequently ___

A

frequent

aysmptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

79% with NAFLD have normal/abnormal ALT

A

NORMAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the be considered about ALT and NAFLD?

A

That both high and normal ALT levels can be associated with the progression of the disease, and no cut-off designated for predicting NASH or advanced fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

We know that ALT is inaccurate is assessing NAFLD, what are other ways to asses? (3)

A
  • Biopsy
  • Imaging
  • Biomarkers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How does transient elastrography (fibroscan) work?

A

The stiffer the liver, the FASTER the shear wave propagate the underlying tissue, measuring CAP (Controlled Attenuation Paramete)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

_____ is the single most important predictor of mortality

A

Fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the increasing prognostic value

A

Ballooning –> NASH –> Portal inflammation –> Fibrosis –>Advanced fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What increases with fibrotic stage?

A

Liver-related and all-cause mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the essential test for diagnosing NASH?

A

Liver biopsy showing steatosis, hepatocyte ballooning and lobular inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why is it unadvised to use clinical, biochemical or imaging measures when diagnosing NASH?

A

Cannot distinguish NASH from steatosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

NAFLD can progress to ___

A

NASH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Clinical predictors of NASH in patients with NAFLD?

A
  • Advanced Age
  • Sex
  • Race
  • HTN, central obesity, dyslipidemia, insulin resistance/diabetes
  • AST/ALT ration >1, low platelets
  • Persistently elevated ALT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Advanced age?

A

Greater duration of disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Sex?

A

Post-menopausal women experience accelerated disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Race?

A

Incr. in hispanic, asian and decr. in blacks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

HTN, central obesity, dyslipidemia, insulin resistance/diabetes?

A

Increase risk wih MetS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

60% prevalence of fibrosis if older that 50 y/o AND obese or diabetic?

A

If pt initially presents with NAFLD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Persistently elevated ALT?
Greater risk of disease progression
26
Gold standard of NAFLD diagnosis?
Liver biopsy
27
Discuss the importance of lifestyle in NAFLD
Unhealthy lifestyle will play a role in the development and progression of NAFLD. Assessment of dietary and PA habits is part of comprehensive NAFLD screening.
28
____ is needed for NASH improvement
Weight-loss
29
Weight loss >/= 10?
Reduces fibrosis in 45% of cases
30
Weight-loss >/= 7% ?
NASH resolution in 64-90%
31
Weight loss >/= 5% ?
Reduces ballooning/inflammation in 41-100%
32
Weight loss >/= 3%?
Steatosis improves in 35-100%
33
______ can improve NASH and fibrosis
Bariatric surgery
34
Macronutrient recommendations?
- Low-to-mod fat and mod-to-high CHO intake - Low-CHO keto diet or high-protein - Med diet
35
Fructose recommendations?
Avoid, contributes to intestinal dysbiota
36
PA recommendations?
150200 min/week of mod intensity PA | -Resistance training
37
What should be considered about PA?
Patient may be experiencing fatigue, and reduce compliance with PA
38
Energy restriction recommendations?
500-1000 kcal res./week - 7-10% weight loss - Long-term maintenance
39
Bottom line on coffee
Protective in NAFLD in reducing histological severity and liver-related outcomes
40
Alcohol in NAFLD?
Recall that NAFLD is CV risk factor, and alcohol can red. CV risk --> recommended 1 drink/day
41
Bottom line on alcohol?
Moderate alcohol consumption (wine) below the risk threshold is associated with lower prevalence of NAFLD, NASH and lower fibrosis and histology.
42
What are recommendations below the risk threshold for alcohol consumption?
30 g men | 20 g women
43
When is total abstinence of alcohol mandatory?
NAHS-cirrhosis, reduce the risk of HCC risk
44
Paradox with alcohol?
Major risk factor for the global disease burden and results in significant loss of health
45
Alcohol and cancer risk?
Risk of death from all causes, and cancers in particular, increase as consumption is increased.
46
What else may be recommended in liver disease?
Vit E supplements (Not an official recommendation) | Pioglitazone (T2DM medication)
47
Why is Vit E not an official recommendation?
- Not recommended without a liver biopsy - Not recommended in mild NAFL with no evidence of NASH - Not recommended in diabetes or cirrhosis
48
When should caution be exerted with Vit E supplementation?
Older men, uncontrolled HTN, Hx of prostate cancer, PMx of stroke/prostate cancer
49
When is pioglitazone recommended?
For biopsy-proven NASH with diabetes or pre-diabetes
50
What should be monitored when on pioglitazone?
- Body weight - ALT and AST - DEXA scan
51
When should pharmacological agents be used?
Reserved with patients with biopsy-proven NASH, and with significant fibrosis.
52
Who else are candidates for pharmacological agents?
Less severe disease but at risk fo progression (diabetes, metS, ALT, inflammation)
53
What is recommended for pts with steatosis alone?
Focus on CVD risk factor modification in primary care, no need for liver clinic
54
How is fibrosis screened?
Surveillance for HCC/varices
55
Treatments for fibrosis?
- Life style intervention/co-morbidities treatment - Bariatric surgery - Pharmacotherapy
56
Most likely cause of death in NAFL/NASH stage 0?
CVD event or extrahepatic cancer
57
Most likely cause of death in NASH stage 1-2?
- CVD event/extahepatic cancer | - Liver-related disease q
58
Most likely cause of death in NASH stage 3-4?
Liver-related diseases
59
Which drug is mostly administered in end-stage NASH?
Selonsertib
60
What is recommended for diabetics with NAFLD?
Glycemic control, pioglitazone
61
When may 800 UI of Vit E be recommended?
Non-diabetics
62
Surgical options for NAFLD?
Bariatric surgery, liver transplantation
63
When a patient has fibrosis/cirrhosis, what next?
treatment and screning for cirrhosis/esophageal varices
64
What is occult cirrhosis?
No sign indicating such diagnosis to clinical
65
What are clinical signs of cirrhosis?
- Thrombocytopenia - Ultrasound signs of liver disease - Splenomegaly - Varices - Ascites
66
When should Hepatocellular Carcinoma (HCC) be screened for pt with NASH cirrhosis?
Every 6 months, where HCC in NAFLD have worse survival
67
HCC in NAFLD are less likely to have ____
curative Tx
68
Should we screen "at-risk" patients for NAFLD/fibrosis?
In Europe, Yes In the US, no But we should
69
What may indicate a high-risk patient who may benefit from screening?
- Age >50 y/o - T2DM - Obesity, dyslipidemia - HIV + - NAFLD at 50-90%
70
What does the MUHC conclude about liver screening?
Diabetic patients have a high prevalence of NAFLD and advanced fibrosis, where those with obesity and dyslipidemia are at high risk --> SCREEN!
71
What other group may be at increased risk for NAFLD, liver fibrosis and cirrhosis?
Inflammatory bowel disease
72
Metabolic risk factors ---> Ultrasound/fibroscan screening ---> steatosis present ---> Normal liver enzymes ---> Serum fibrosis markers Low risk?
continue to follow-up with liver enzymes in 2 yrs.
73
Metabolic risk factors ---> Ultrasound/fibroscan screening ---> steatosis present ---> Normal liver enzymes ---> Serum fibrosis markers med/high risk?
Refer to specialist, and identify other chronic liver diseases, assess severity, may perform biopsy
74
Metabolic risk factors ---> Ultrasound/fibroscan screening ---> steatosis present ---> Abnormal liver enzymes?
Refer to specialist, and identify other chronic liver diseases, assess severity, may perform biopsy
75
Metabolic risk factors ---> Ultrasound/fibroscan screening ---> steatosis ABSENT ---> Normal liver enzymes ?
Follow-up 3/5 yrs with ultrasound/liver enzymes
76
Metabolic risk factors ---> Ultrasound/fibroscan screening ---> steatosis ABSENT ---> Abnormal liver enzymes?
Refer to specialist, and identify other chronic liver diseases, assess severity, may perform biopsy
77
NAFLD is the most _____ in western countries
frequent
78
NADLT is ______ disease which requires a multi-disciplinary approach
multi-system
79
What is the strongest prognostic predictor?
Liver fibrosis stage, where 3-4 has the worst prognosis

Clinical Nutrition 1 (30 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions